News

Kendra Mehling Joins Discern Health as a Project Analyst

October 2019

Kendra Mehling recently joined Discern Health as a project analyst. She brings a public health focus to her work and currently supports projects related to oncology clinical pathways, diabetes, and value-based care. Kendra has experience in chronic disease prevention, pharmaceutical policy, and community health initiatives. Prior to joining Discern, Kendra completed a fellowship with Novo…

Read more

CMMI Acting Director Presentation Summary: Future of Payment in Post-Acute & Long-Term Care

October 2019

On September 23, Center for Medicare and Medicaid Innovation (CMMI) Acting Director Amy Bassano joined an Advancing Excellence in Long-Term Care Collaborative (AELTCC) meeting, which was hosted at Discern Health’s Washington, DC office. During the meeting, she presented on the future of payment in post-acute and long-term care, provided updates on relevant payment models, and…

Read more

Perspectives on the Current Oncology Value-Based Care Landscape from the NCCN Policy Summit

October 2019

On September 12, Discern attended the National Comprehensive Cancer Network (NCCN) Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care. The summit presented diverse perspectives related to defining, measuring, and paying for quality as cancer care is inundated with innovative, personalized, and high-cost interventions. Experts…

Read more

C-TAC Webinar Summary: Innovative Solutions & Best Practices for Improving Advance Care Planning

October 2019

Many factors can prevent individuals from examining, expressing, and documenting their wishes when faced with serious illness. On September 19, Discern Health Director Theresa Schmidt presented innovative solutions for improving access to advance care planning during the Coalition to Transform Advanced Care (C-TAC) webinar, Identifying and Overcoming Barriers to Advance Care Planning. Theresa joined industry colleagues from…

Read more

Guy D’Andrea Appointed to Robert Wood Johnson Foundation Steering Committee to Advance Health Equity

October 2019

Discern Health Managing Partner Guy D’Andrea was recently appointed to a project steering committee focused on cross-sector measurement to advance health equity. The project, which is funded by the Robert Wood Johnson Foundation and led by the American Institutes for Research, will explore measurement as a catalyst for alignment across the health care, public health,…

Read more

MedTech Panel Summary: Strategic Uses of Real World Evidence to Demonstrate Value

October 2019

On September 25, Discern Health Partner Tom Valuck moderated the expert panel “Strategic Use of Post-Market Real World Evidence (RWE) to Demonstrate Value” during MedTech 2019 in Boston, MA. The panel was composed of health care data analytics and RWE innovation experts from The OCI Group, LLC; Milliman, Inc.; and Archimedic. The presentation focused on…

Read more

Summary of the Latest Recommendations from the ASCO Quality Care Symposium

September 2019

The 2019 American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Diego, CA presented the latest strategies and methods for quantification of patient experience, provider efficiency, clinical outcomes, and quality and safety in the cancer care field. This year, oncology quality experts focused on topics such as the quality of care across multisite…

Read more

Discern Authors AJMC Article on the Impact of Quality Measures on Life Sciences Companies

September 2019

In partnership with Novartis Pharmaceuticals, Discern Health recently authored an article published in the American Journal of Managed Care, “Improving Quality Measure Maintenance: Navigating the Complexities of Evolving Evidence.” The article’s authors, including Discern Partner Tom Valuck, highlight the importance of ensuring that life sciences companies have quality strategies in place to update guidelines and…

Read more

Quality Outlook: Discern and the Journal of Clinical Pathways Launch a New Blog Series

September 2019

Discern Health and the Journal of Clinical Pathways (JCP) have launched a new oncology-focused commentary series, Quality Outlook. The series, authored by JCP editorial board member and Discern Partner Tom Valuck and other Discern subject matter experts, explores key issues related to oncology quality and value, such as measurement, value-based payment, and quality improvement of…

Read more

Theresa Schmidt Presents Innovative Solutions for Improving Advance Care Planning

August 2019

On September 19, Discern Health Director Theresa Schmidt will join industry colleagues from Vital Decisions, HopeHealth, and Stratis Health for the Coalition to Transform Advanced Care (C-TAC) webinar, Identifying and Overcoming Barriers to Advance Care Planning. During the webinar, panelists will discuss the latest research on best practices and regional variation in strategies for addressing…

Read more

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO